Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries G1 Therapeutics Inc (NQ: GTHX ) 3.930 +0.160 (+4.24%) Streaming Delayed Price Updated: 12:46 PM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 462,460 Open 3.520 Bid (Size) 3.930 (2) Ask (Size) 3.940 (3) Prev. Close 3.770 Today's Range 3.520 - 3.960 52wk Range 1.080 - 5.000 Shares Outstanding 42,705,532 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News GTHX Stock Earnings: G1 Therapeutics Beats EPS, Misses Revenue for Q1 2024 Today 10:54 EDT GTHX stock results show that G1 Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights Today 6:30 EDT From G1 Therapeutics Via GlobeNewswire Performance YTD +26.37% +26.37% 1 Month -13.63% -13.63% 3 Month +3.69% +3.69% 6 Month +138.18% +138.18% 1 Year +27.60% +27.60% More News Read More G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib Today 6:25 EDT From G1 Therapeutics Via GlobeNewswire Breaking Down G1 Therapeutics: 5 Analysts Share Their Views April 12, 2024 Via Benzinga Forecasting The Future: 5 Analyst Projections For G1 Therapeutics February 28, 2024 Via Benzinga Biotech Innovations Paving the Way in Breast Cancer Fight April 11, 2024 Via FinancialNewsMedia Topics Death Exposures Death Product Safety 12 Health Care Stocks Moving In Monday's Pre-Market Session April 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 28, 2024 Via Benzinga G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights February 28, 2024 From G1 Therapeutics Via GlobeNewswire Why Is Breast Cancer-Focused G1 Therapeutics Stock Trading Lower Today? February 13, 2024 Via Benzinga Exposures Product Safety Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 13, 2024 Via Benzinga Evercore ISI Is Warming Up to NextEra Energy (NEE) Stock February 13, 2024 Via InvestorPlace UBS Just Upped Its Nvidia (NVDA) Stock Price Target February 13, 2024 Via InvestorPlace Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket February 13, 2024 Via Benzinga Why Is Polished.com (POL) Stock Down 33% Today? February 13, 2024 Via InvestorPlace Why Is G1 Therapeutics (GTHX) Stock Down 45% Today? February 13, 2024 Via InvestorPlace ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For Tuesday February 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 13, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday February 13, 2024 Via InvestorPlace Arista Networks Reports Q4 Results, Joins Teradata, Lattice Semiconductor And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session February 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 12, 2024 Via Benzinga G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee February 12, 2024 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference January 08, 2024 From G1 Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session December 11, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
